Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Use of Acetylsalicylic Acid (ASA) for Enhanced Early Detection of Colorectal Neoplasms
DRKS00003252Phase 3Completed
- Sponsor
- German Cancer Research Center
- Start
- Mar 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in colorectal cancer (CRC) comparing ASA 300 mg with Placebo (2 arms). Primary endpoint: Diagnostic performance of iFOBTs after ASA vs placebo. Started Mar 2013; status: completed.
02
Drugs
aspirin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on DRKS00003252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00003252.